Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Derek Pineda

Nurse Practitioner, Family New York, NY Nurse Practitioner

NPI 1659750636 CMS profile 10658102

1 Gustave L Levy Pl, New York, NY 10029

Open in the dashboard

General payments

$37,956

513 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derek Pineda of New York, NY is reported in the CMS Open Payments database as having received $37,956 across 513 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,069 93
2024 General $10,904 146
2023 General $6,108 83
2022 General $9,308 114
2021 General $6,567 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Pineda
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Derek Pineda were reported at $5,069. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Derek Pineda Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $6,567 $124 $35–$379 $132
2022 $9,308 $141 $44–$430 $149
2023 $6,108 $154 $49–$476 $160
2024 $10,904 $165 $51–$504 $164
2025 $5,069 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $16,034 79 payments
  2. Medtronic, Inc. $5,826 53 payments
  3. Shockwave Medical, Inc $4,038 38 payments
  4. Janssen Pharmaceuticals, Inc $1,706 42 payments
  5. Tactile Systems Technology Inc $1,644 34 payments
  6. Amgen Inc. $1,431 52 payments
  7. Abiomed $1,237 37 payments
  8. Boston Scientific Corporation $1,215 17 payments
  9. Scpharmaceuticals Inc. $884 11 payments
  10. Abbott Laboratories $796 20 payments
  11. Other $3,145 130 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $20,017 456 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,000 21 payments
  3. Travel and Lodging $3,180 32 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $1,250 1 payment
  5. Consulting Fee $390 1 payment
  6. Education $120 2 payments
Products named General payments · program years 2021–2025
  1. LOKELMA $15,143 64 payments
  2. SYMPLICITY G3 $4,409 41 payments
  3. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $3,502 31 payments
  4. XARELTO $1,706 42 payments
  5. Flexitouch Plus $1,644 34 payments
  6. entre $1,257 27 payments
  7. Repatha $1,031 41 payments
  8. FUROSCIX $884 11 payments
  9. Impella $752 23 payments
  10. COREVALVE EVOLUT R $664 6 payments
  11. Other $6,819 206 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

513 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record